These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 22136096

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment moderators and predictors of outcome in the Treatment of Early Age Mania (TEAM) study.
    Vitiello B, Riddle MA, Yenokyan G, Axelson DA, Wagner KD, Joshi P, Walkup JT, Luby J, Birmaher B, Ryan ND, Emslie G, Robb A, Tillman R.
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):867-78. PubMed ID: 22917200
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents.
    Geller B, Luby JL, Joshi P, Wagner KD, Emslie G, Walkup JT, Axelson DA, Bolhofner K, Robb A, Wolf DV, Riddle MA, Birmaher B, Nusrat N, Ryan ND, Vitiello B, Tillman R, Lavori P.
    Arch Gen Psychiatry; 2012 May; 69(5):515-28. PubMed ID: 22213771
    [Abstract] [Full Text] [Related]

  • 8. Double-blind randomized trial of risperidone versus divalproex in pediatric bipolar disorder: fMRI outcomes.
    Pavuluri MN, Passarotti AM, Lu LH, Carbray JA, Sweeney JA.
    Psychiatry Res; 2011 Jul 30; 193(1):28-37. PubMed ID: 21592741
    [Abstract] [Full Text] [Related]

  • 9. The influence of risperidone on attentional functions in children and adolescents with attention-deficit/hyperactivity disorder and co-morbid disruptive behavior disorder.
    Günther T, Herpertz-Dahlmann B, Jolles J, Konrad K.
    J Child Adolesc Psychopharmacol; 2006 Dec 30; 16(6):725-35. PubMed ID: 17201616
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM, Withney JE, Korndörfer SR, Tilley CA, Mrakotsky C, Gonzalez-Heydrich JM.
    J Psychiatr Pract; 2008 May 30; 14(3):160-9. PubMed ID: 18520785
    [Abstract] [Full Text] [Related]

  • 12. Risperidone and divalproex differentially engage the fronto-striato-temporal circuitry in pediatric mania: a pharmacological functional magnetic resonance imaging study.
    Pavuluri MN, Passarotti AM, Fitzgerald JM, Wegbreit E, Sweeney JA.
    J Am Acad Child Adolesc Psychiatry; 2012 Feb 30; 51(2):157-170.e5. PubMed ID: 22265362
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Placebo-controlled trial of valproic Acid versus risperidone in children 3-7 years of age with bipolar I disorder.
    Kowatch RA, Scheffer RE, Monroe E, Delgado S, Altaye M, Lagory D.
    J Child Adolesc Psychopharmacol; 2015 May 30; 25(4):306-13. PubMed ID: 25978742
    [Abstract] [Full Text] [Related]

  • 16. Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder.
    Saxena K, Howe M, Simeonova D, Steiner H, Chang K.
    J Child Adolesc Psychopharmacol; 2006 Jun 30; 16(3):252-9. PubMed ID: 16768633
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.